DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Zenith Drugs Limited (ZENITHDRUG) share price today?

Zenith Drugs Limited (ZENITHDRUG) is trading at ₹41.4 on the NSE, up 3.50% on the day. Source: DocStoX.

What is the PE ratio of Zenith Drugs Limited?

Zenith Drugs Limited has a price-to-earnings (PE) ratio of 18.0 in the Healthcare sector.

What is the market capitalisation of Zenith Drugs Limited?

Zenith Drugs Limited has a market capitalisation of approximately ₹70 crore.

Is Zenith Drugs Limited a profitable company?

Zenith Drugs Limited generates a return on equity of 5.4% with a net profit margin of 2.3%. That is a modest return on shareholder capital.

What is the 52-week high and low of ZENITHDRUG?

Zenith Drugs Limited (ZENITHDRUG) has traded between ₹33.3 and ₹65.5 over the past 52 weeks, against a current price of ₹41.4.

Does Zenith Drugs Limited pay a dividend?

Yes. Zenith Drugs Limited currently offers a dividend yield of 1.08%. Dividend payments depend on the board's declaration each year.

Zenith Drugs Limited

₹41.40▲ +1.40 (+3.50%)

ZENITHDRUG·NSE·Healthcare

Market Cap

69.62 Cr

PE Ratio

18.00

Volume

13,600

Day High - Low

41.40 - 38.00

52W High-Low

65.50 - 33.30

₹41.40▲ +1.40 (+3.50%)

Market Cap69.62 Cr

PE Ratio18.00

Volume13,600

Day High - Low41.40 - 38.00

52W High-Low65.50 - 33.30

Zenith Drugs Limited (ZENITHDRUG): company summary

The company's revenue rose 29.7% annually, but net profit fell 43.7% year-on-year.

Zenith Drugs Limited (ZENITHDRUG) is a micro-cap Healthcare company valued at ₹70 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move: Zenith Drugs Limited last traded at ₹41.4, up 3.50% on the day.
Financial performance: The company's revenue rose 29.7% annually, but net profit fell 43.7% year-on-year. The latest quarter saw revenue rise 40.9% compared to the same quarter a year earlier, while net profit doubled to ₹2 crore from ₹1 crore.
Valuation multiples: The stock trades at 18.0 times earnings, a discount to the Healthcare median of 32.0, 1.06 times book value. It yields 1.1%.
Things to watch: The net profit margin narrowed 3.0 percentage points to 2.3%. The company's return on equity is 5.4%, below the return on capital employed of 8.6%. The stock is 37.1% below its 52-week high.
Where it stands: The company's revenue growth outpaced profit growth, with net profit falling 43.7% annually. The latest quarter's net profit doubled, but the net profit margin remains low at 2.3%. The stock is 37.1% below its 52-week high.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

4.2/10

Weak

Fair Value

ROE

5.38%

Weak

P/E

18.00x

Fair

Debt / Equity

0.75

Moderate

Industry

Healthcare

Pharmaceuticals

Overall View

Weak

Price performance

Day₹38.00

₹41.40

52W₹33.30

₹65.50

DocStoX take

Supported by risk (6.4), but held back by momentum (1.5).

DocStoX score

Low confidence

4.2

/10

Weak

Quality

Weak

ROE 5.4%

Valuation

Fair

P/E 18.0×

Growth

Steady

Revenue +18.9% 5Y CAGR

Risk

Moderate

D/E 0.75

Momentum

Weak

25% of 52-week range

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹41

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹70 Cr

52W High / Low

₹66 / ₹33

Dividend Yield

1.08%

Promoter Holding

69.98%

EPS (TTM)

₹2.30

Book Value

₹42.76

Key highlights

Profitable in all of the last 5 years
Revenue compounding 19% a year
Quality is weak (2.2/10)
Momentum is weak (1.5/10)

2 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Explore Zenith Drugs Limited’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Zenith Drugs Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Laurus Labs Limited Cipla Limited Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited Mankind Pharma Limited Lupin Limited Manipal Health Enterprises Limited

Compare Zenith Drugs Limited with peers

Zenith Drugs Limited vs Sun Pharmaceutical Industries Limited Zenith Drugs Limited vs Divi's Laboratories Limited Zenith Drugs Limited vs Torrent Pharmaceuticals Limited Zenith Drugs Limited vs Apollo Hospitals Enterprise Limited Zenith Drugs Limited vs Zydus Lifesciences Limited Zenith Drugs Limited vs Laurus Labs Limited

Related tools & concepts

Value Zenith Drugs Limited with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

ZENITHDRUG newsLatest coverage & filings Open screenerFilter the whole market